Synthesis and HIV-1 reverse transcriptase inhibition properties of two new methylenephosphonate analogues of 3′-azido-3′-deoxythymidine-5′-triphosphate
- 1 October 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (20) , 2315-2320
- https://doi.org/10.1016/0960-894x(95)00401-e
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Rational design for cytosolic delivery of nucleoside monphosphates : “SATE” and “DTE” as enzyme-labile transient phosphate protecting groupsPublished by Elsevier ,2001
- Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA BIS(SATE)phosphotriester and 3′-azido-2′,3′-dideoxythymidineBiochemical Pharmacology, 1994
- Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation processAntiviral Research, 1993
- New thymidine triphosphate analog inhibitors of human immunodeficiency virus-1 reverse transcriptase.Journal of Medicinal Chemistry, 1992
- Synthesis of a difluoromethylenephosphonate analogue of AZT 5'-triphosphate and its inhibition of HIV-1 reverse transcriptaseBioorganic & Medicinal Chemistry Letters, 1991
- ga,β- and β,γ-methylene 5'-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine-5'-triphosphateBiochemical Pharmacology, 1988
- CHLOROMETHYL–PHOSPHORUS COMPOUNDS SYNTHESIS AND INFRARED SPECTRACanadian Journal of Chemistry, 1966
- Nucleosides. V. The Monomesylates of 1-(2'-Deoxy-β-D-lyxofuranosyl)thymine1,2The Journal of Organic Chemistry, 1964
- Nucleotides-IIIBiochemical Pharmacology, 1962
- THE UTILIZATION OF NUCLEOTIDES BY THE MAMMALPublished by Elsevier ,1956